Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2010.06.034PMID 20816198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis.

  2009cited by this paper
• Implementation of Guidelines for Allergic Rhinitis in Specialist Practices

  2009cited by this paper
• Unmet needs in severe chronic upper airway disease (SCUAD).

  2009cited by this paper
• A survey of the burden of allergic rhinitis in Europe.

  2008cited by this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cited by this paper
• ARIA (Allergic Rhinitis and Its Impact on Asthma) Classification of Allergic Rhinitis Severity in Clinical Practice in France

  2007cited by this paper
• A survey of the burden of allergic rhinitis in Europe

  2007cited by this paper
• Original article: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines

  2007cited by this paper
• Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine

  2005cited by this paper
• The visual analogue scale: Its use in pain measurement

  2004cited by this paper
• Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

  2003cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire.

  1999cited by this paper
• International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group.

  1994cited by this paper
• Soluble markers of allergic inflammation

  1994cited by this paper
• The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

  1993cited by this paper
• A critical review of visual analogue scales in the measurement of clinical phenomena.

  1990cited by this paper
• Measuring change over time: assessing the usefulness of evaluative instruments.

  1987cited by this paper

• Allergen-specific human IgE isolated through an allergen-agnostic pipeline—understanding immune response and allergen recognition

  2026cites this paper
• POSSIBILITIES OF ACHIEVEMENT CONTROL ALLERGIC RNINITIS IN PATIENTS WITH EPIDERMAL SENSIBILIZATION AND CONTINUED CONTACT WITH PETS

  2025cites this paper
• Recommendations for allergy-friendly urban planting in the context of climate change

  2025cites this paper
• Efficacy and safety of mometasone and olopatadine combination for nasal use in patients with allergic rhinitis caused by sensitization to epidermal allergens in continuous exposure

  2025cites this paper
• LP‐003, a novel high‐affinity anti‐IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled phase 2 clinical trial

  2025cites this paper
• Interleukin-4-Mediated NLRP3 Inflammasome Activation in Microglia Contributes to Allergic Rhinitis via Central Sensitization

  2025cites this paper
• Empfehlung zur allergikerfreundlichen Bepflanzung von Städten unter Berücksichtigung des Klimawandels

  2025cites this paper
• Subcutaneous Allergen Immunotherapy in Adults Allergic to House Dust Mites: A Phase 3 Randomized Controlled Trial

  2025cites this paper
• A comparative study of efficacy and tolerability of cetirizine and bilastine in patients of allergic rhinitis: An open-label, randomized, parallel-group study

  2025cites this paper
• Insufficiency of Laboratory Data in Reflecting Allergic Rhinitis Severity Based on the Allergic Rhinitis and Its Impact on Asthma Guideline in Korean Patients

  2024influential citation
• Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®

  2024cites this paper
• Advanced Therapy of Allergic Rhinitis: Possibilities, Limitations and Prospects

  2023cites this paper
• Features of clinical signs and treatment of allergic rhinitis in patients with different types of nasal septum deviation

  2023cites this paper
• Determinants of uncontrolled allergic rhinitis in Kinshasa hospitals

  2023cites this paper
• Effects of modified posterior nasal nerve neurectomy combined with accessory posterior nasal nerve neurectomy on controlling intractable allergic rhinitis.

  2023cites this paper
• Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis

  2023cites this paper
• Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis

  2023cites this paper
• Algorithm of allergic rhinitis treatment in patients with various types of nasal septum deviation

  2023cites this paper
• Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment

  2022cites this paper
• Combination therapy of allergic rhinitis: efficacy, safety and impact on quality of life

  2022cites this paper
• Major considerations and clinical findings on the allergic conjunctivitis: a narrative and systematic review

  2022cites this paper
• New opportunities in the allergic rhinitis therapy

  2021cites this paper
• The clinical features of intractable allergic rhinitis based on a questionnaire administered to clinicians.

  2021cites this paper
• Relationship between Poorly Controlled Asthma and Sleep-Related Breathing Disorders in Children with Asthma: A Two-Center Study

  2021cites this paper
• Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis

  2021cites this paper
• A Prospective Study to Compare Clinical Outcomes of Allergic Rhinitis Between Older and Younger Adults: A Potential Effect of Depression in Older Patients

  2020cites this paper
• Grand Challenges in Rhinology

  2020cites this paper
• Can a Pretreatment Visual Analog Scale Predict Treatment Outcome in Allergic Rhinitis?

  2020cites this paper
• The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients

  2020cites this paper
• Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice

  2020cites this paper
• Histology-based blood leukocyte profiling reveals parallel Th2 and Th17 signatures in seasonal allergic rhinitis

  2020cites this paper
• Clinical Study on Acupuncture Treatment of Perennial Allergic Rhinitis (PAR) Based on Zelen’s Design

  2020cites this paper
• Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

  2019cites this paper
• Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement

  2019cites this paper
• IL-35 Inhibited Th17 Response in Children with Allergic Rhinitis

  2019cites this paper
• Pattern of uncontrolled allergic rhinitis in a hospital setting of Kinshasa, Democratic Republic of Congo

  2019cites this paper
• The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

  2019cites this paper
• Rhinitis, sinusitis, and ocular allergy Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

  2019cites this paper
• Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management

  2018cites this paper
• Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

  2018cites this paper
• Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS

  2018cites this paper
• Treatment history and association between allergic rhinitis symptoms and quality of life

  2018cites this paper
• Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis

  2018cites this paper
• Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory disease

  2018influential citation
• HEUSCHNUPFEN – Hatschi & Co

  2018cites this paper
• A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis

  2018cites this paper
• RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients

  2018cites this paper
• Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

  2017cites this paper
• Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care

  2017cites this paper
• Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK

  2017cites this paper
• Quality of Life in Pediatric Patients with Allergic Rhinitis treated at the Medical Clinic of Integrated Education – Unisul

  2017cites this paper
• CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

  2017cites this paper
• Control of Allergic Rhinitis and Asthma Test for Children (CARATKids): Validation in Brazil and cutoff values.

  2017cites this paper
• Management of allergic rhinitis in the era of effective over-the-counter treatments

  2017cites this paper
• Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

  2017cites this paper
• Visuelle Analogskalen (VAS) als Messinstrumente zur Dokumentation der Symptomatik und Therapiekontrolle einer allergischen Rhinitis in der Routineversorgung

  2017influential citation
• Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease.

  2017cites this paper
• Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis.

  2017cites this paper
• Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life

  2017cites this paper
• Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

  2017cites this paper
• Assoziation zwischen Kontrolle der allergischen Rhinitis und Schlafqualität

  2017cites this paper
• Assoziation zwischen Kontrolle der allergischen Rhinitis und Schlafqualität Hintergrund

  2017cites this paper
• Overall and peripheral lung function assessment by spirometry and forced oscillation technique in relation to asthma diagnosis and control

  2017cites this paper
• Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe.

  2017cites this paper
• Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA).

  2017influential citation
• Acute Otitis Media in Children Cleft Lip Alveolus and Palate Allergic Rhinitis in Adults Acute Bacterial Rhinosinusitis in Adults Chronic Rhinosinusitis in Adults

  2017cites this paper
• Characterization of Pollen Specific Proteins SF3 and SF21 from Sunflower ( Helianthus annuus L . ) for the Allergenicity Potential

  2016cites this paper
• UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study

  2016cites this paper
• ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

  2016cites this paper
• MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.

  2016cites this paper
• Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis

  2016cites this paper
• Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis

  2016cites this paper
• MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.

  2016cites this paper
• Corticosteroid hypersensitivity in allergic rhinitis.

  2016cites this paper
• Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.

  2016cites this paper
• The epidemiology survey of uncontrolled allergic rhinitis and allergic rhinitis control test questionnaire-driven stepwise pharmacotherapy in Wuhan

  2016cites this paper
• Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period

  2016cites this paper
• Clinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study

  2016cites this paper
• MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis.

  2015cites this paper
• Which clinical indicators for the control of allergic rhinitis

  2015cites this paper
• Clinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study

  2015cites this paper
• Jakość życia w alergicznym nieżycie nosa

  2015cites this paper
• Current controversies and challenges in allergic rhinitis

  2015cites this paper
• Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.

  2015cites this paper
• Current controversies and challenges in allergic rhinitis management

  2015influential citation
• Consensus document on allergic conjunctivitis (DECA).

  2015influential citation
• A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress

  2015cites this paper
• Allergen Immunotherapy (AIT): a prototype of Precision Medicine

  2015cites this paper
• Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

  2015cites this paper
• A new AR therapy (MP29-02*): all of ARIA in one puff

  2015cites this paper
• MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

  2015influential citation
• The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey

  2015cites this paper
• Escaping the trap of allergic rhinitis

  2015cites this paper
• The need for clinical indicators in allergic rhinitis

  2015cites this paper
• Prise en charge de la rhinite allergique : une question d’actualité

  2015cites this paper
• Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.

  2014cites this paper
• Prevalence of Uncontrolled Allergic Rhinitis in Wuhan, China: A Prospective Cohort Study

  2014cites this paper
• Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care

  2013cites this paper
• Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

  2013influential citation
• Patient-reported outcomes in respiratory allergic disease, with special focus on health-related quality of life

  2013cites this paper